{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:29Z","timestamp":1792979909535,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This case discusses the challenges created by COVID-19 (coronavirus disease 2019) in the area of hormonal contraception, highlighting the contraception knowledge gap for women in their post COVID-19 period, especially if they had high D-dimer levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This case involves a thirty-eight-year-old woman taking combined oral contraception (desogestrel\/ethinyl oestradiol tablets) with a history of varicose veins. She recovered from a COVID-19 infection in November 2020. She presented to the emergency room with right lower-limb pain below the knee and progressive swelling for five days in February 2021. Physical examination of the lower limb showed mild swelling and tenderness of the right leg compared to the left leg. D-Dimer was elevated (1.06\u00a0mcg\/mL FEU). COVID-19 screening was negative. A Doppler scan to exclude DVT was performed considering the clinical picture and high D-dimer level. There was no evidence of DVT in the right limb. She was reassured and discharged with instructions on when to visit the emergency room. The D-dimer had decreased to 0.53\u00a0mcg\/mL FEU in March 2021. She booked an appointment with family medicine clinics because she was concerned about the continuation of combined oral contraception (desogestrel\/ethinyl oestradiol tablets) with high D-dimer and risk of thrombosis. The follow-up D-dimer level in May 2021 was normal (0.4\u00a0mcg\/mL FEU). The patient preferred to continue taking oral contraception.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>An evidence-based consensus is needed to guide clinicians in providing contraception counselling for such patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-021-01456-5","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T13:02:44Z","timestamp":1630155764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An oral combined contraceptive user with elevated D-dimer post COVID-19: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-425X","authenticated-orcid":false,"given":"Nada A.","family":"Alyousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"6","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438.","journal-title":"Lancet Haematol."},{"issue":"9","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/jth.14975","volume":"18","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103\u20139.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3949\/ccjm.87a.ccc024","volume":"87","author":"SR Mucha","year":"2020","unstructured":"Mucha SR, Dugar S, McCrae K, Joseph DE, Bartholomew J, Sacha G, et al. Coagulopathy in COVID-19. Cleve Clin J Med. 2020;87(8):461\u20138.","journal-title":"Cleve Clin J Med"},{"key":"1456_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813.pub2","author":"M de Bastos","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama VA, Helmerhorst FM, Stijnen T, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD010813.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1456_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014908","author":"MA Cohen","year":"2021","unstructured":"Cohen MA, Stewart F, Paynter R, Edelman A, Henderson J. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD014908.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1456_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-020-00453-4","volume":"8","author":"Z Huang","year":"2020","unstructured":"Huang Z, Yao Y, Cao J, Wang Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8(1):1\u201311.","journal-title":"J Intensive Care"},{"issue":"5","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1055\/s-0040-1709650","volume":"120","author":"G Lippi","year":"2020","unstructured":"Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020;120(5):876.","journal-title":"Thromb Haemost"},{"key":"1456_CR8","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization; 2020.","DOI":"10.15557\/PiMR.2020.0004"},{"issue":"4","key":"1456_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/thoraxjnl-2020-215818","volume":"76","author":"S Mandal","year":"2021","unstructured":"Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. Long-COVID: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396\u20138.","journal-title":"Thorax"},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"b2921","DOI":"10.1136\/bmj.b2921","volume":"339","author":"VA van Hylckama","year":"2009","unstructured":"van Hylckama VA, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921.","journal-title":"BMJ"},{"key":"1456_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0049-3848(13)70009-4","volume":"131","author":"PM Sandset","year":"2013","unstructured":"Sandset PM. Mechanisms of hormonal therapy related thrombosis. Thromb Res. 2013;131:S4-7.","journal-title":"Thromb Res"},{"key":"1456_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.thromres.2021.03.012","volume":"202","author":"L Skeith","year":"2021","unstructured":"Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: how strong a risk factor for venous thromboembolism? Thromb Res. 2021;202:134\u20138.","journal-title":"Thromb Res"},{"issue":"10","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/2047487318774847","volume":"25","author":"M Glisic","year":"2018","unstructured":"Glisic M, Shahzad S, Tsoli S, Chadni M, Asllanaj E, Rojas LZ, et al. Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25(10):1042\u201352. https:\/\/doi.org\/10.1177\/2047487318774847.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM. Progestin-only contraception and thromboembolism: a systematic review. Contraception. 2016;94(6):678\u2013700.","journal-title":"Contraception"},{"issue":"3","key":"1456_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.contraception.2015.03.010","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Marchbanks PA, Curtis KM. Superficial venous disease and combined hormonal contraceptives: a systematic review. Contraception. 2016;94(3):275\u20139.","journal-title":"Contraception"},{"key":"1456_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.maturitas.2020.04.019","volume":"137","author":"I Ram\u00edrez","year":"2020","unstructured":"Ram\u00edrez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, et al. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia and Sociedad Espa\u00f1ola de Trombosis y Hemos. Maturitas. 2020;137:57\u201362.","journal-title":"Maturitas"},{"key":"1456_CR17","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946202062063","author":"HT Vechi","year":"2020","unstructured":"Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo. 2020. https:\/\/doi.org\/10.1590\/S1678-9946202062063.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1456_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.thromres.2020.05.015","volume":"192","author":"PC Nauka","year":"2020","unstructured":"Nauka PC, Oran E, Chekuri S. Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection. Thromb Res. 2020;192:27\u20138.","journal-title":"Thromb Res"},{"issue":"1","key":"1456_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13625187.2020.1849618","volume":"26","author":"CS Kow","year":"2021","unstructured":"Kow CS, Mustafa ZU, Hasan SS. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Heal Care. 2021;26(1):85\u20136. https:\/\/doi.org\/10.1080\/13625187.2020.1849618.","journal-title":"Eur J Contracept Reprod Heal Care"},{"issue":"3","key":"1456_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijgo.12455","volume":"141","author":"MV Dragoman","year":"2018","unstructured":"Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynecol Obstet. 2018;141(3):287\u201394.","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"1456_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","volume":"64","author":"S Hennessy","year":"2001","unstructured":"Hennessy S, Berlin JA, Kinman JL, Margolis DJ, Marcus SM, Strom BL. Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis. Contraception. 2001;64(2):125\u201333.","journal-title":"Contraception"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01456-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01456-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01456-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T13:03:02Z","timestamp":1630155782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01456-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01456-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Reporting this case was done according to the Declaration of Helsinki's ethical principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declared that she has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}